About this trial
This randomized controlled trial study aimed to measure the effectiveness of the combination of 4-weeks Buteyko breathing exercises and pharmacological therapy compared with pharmacological therapy alone in children with uncontrolled asthma.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Children aged 7-17 years
Uncontrolled or partially controlled asthma (GINA Symptom Control Tool score > 1)
Receive bronchodilator therapy, either oral or inhaler from a pediatrician.
Children and parents/care givers agree to participate in the study until the end, and parents/care givers sign the informed consent form.
Disqualifiers
Inpatients
Have received Buteyko breathing exercises or other breathing exercises.
Have congenital heart disease, pneumonia, or other significant and uncontrolled health disorders.
Have severe physical disabilities or mental retardation that could potentially prevent the implementation of Buteyko breathing exercises.
Trial design
Parallel
Treatments tested in this trial
Buteyko
BehavioralThe Buteyko breathing exercise is a method that encourages nasal breathing, reducing breathing volume, and using breath-holding exercises to normalize breathing pattern
Asthma reliever and controller
DrugAsthma reliever and controller according to GINA (Global Initiative for Asthma) guideline
Treatment groups
Trial outcomes
Primary outcomes
Asthma control
Level of asthma control measured by Asthma Control Questionnaire (ACQ) - Indonesian version. Minimum value 0, maximum value 6. Higher score means worse outcome.
Secondary outcomes
Asthma Quality of Life
Measured by Pediatric Asthma Quality of Life Questionnaire standardized version (PAQLQ(S)) - Indonesian version. Minimum value 1, maximum value 7. Higher scores means better outcome.
Bronchodilator use
Bronchodilator use measured by logbook, recorded by caregiver of patients
FEV1
Forced Expiratory Volume in one second reflects degree of airway obstruction. Measured by spirometry.
FVC
Forced Vital Capacity is total volume of air that can forcefully exhale after taking the deepest possible breath. Measured by spirometry.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Ivan Sofian Wibowo
Lead sponsor
Indonesia University
Sponsor institution
Fakultas Kedokteran Universitas Indonesia
Collaborator
Dr Cipto Mangunkusumo General Hospital
Collaborator
This trial is not recruiting at the moment. You can still explore other options: